Atala Financial Inc Has $1.80 Million Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Atala Financial Inc raised its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 2.9% in the 1st quarter, HoldingsChannel reports. The firm owned 22,289 shares of the company’s stock after buying an additional 636 shares during the period. GE HealthCare Technologies makes up approximately 1.3% of Atala Financial Inc’s holdings, making the stock its 22nd largest holding. Atala Financial Inc’s holdings in GE HealthCare Technologies were worth $1,798,000 at the end of the most recent reporting period.

Several other hedge funds have also added to or reduced their stakes in GEHC. CoreFirst Bank & Trust acquired a new position in shares of GE HealthCare Technologies in the fourth quarter valued at approximately $25,000. Runnymede Capital Advisors Inc. bought a new stake in GE HealthCare Technologies in the 4th quarter valued at $28,000. LGT Financial Advisors LLC grew its holdings in GE HealthCare Technologies by 46.2% in the 4th quarter. LGT Financial Advisors LLC now owns 389 shares of the company’s stock valued at $30,000 after buying an additional 123 shares in the last quarter. Accredited Wealth Management LLC bought a new position in GE HealthCare Technologies during the 4th quarter worth $30,000. Finally, Ameriflex Group Inc. bought a new position in GE HealthCare Technologies during the 4th quarter worth $31,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms recently commented on GEHC. The Goldman Sachs Group decreased their price target on shares of GE HealthCare Technologies from $94.00 to $82.00 and set a “buy” rating on the stock in a research note on Thursday, May 1st. BTIG Research set a $95.00 target price on shares of GE HealthCare Technologies and gave the stock a “buy” rating in a report on Monday, April 14th. Morgan Stanley cut their price target on GE HealthCare Technologies from $86.00 to $78.00 and set an “equal weight” rating for the company in a research note on Tuesday, May 6th. Wall Street Zen raised GE HealthCare Technologies from a “hold” rating to a “buy” rating in a research report on Saturday, May 31st. Finally, Piper Sandler cut their target price on GE HealthCare Technologies from $104.00 to $88.00 and set an “overweight” rating for the company in a research report on Wednesday, April 23rd. Three analysts have rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, GE HealthCare Technologies presently has a consensus rating of “Moderate Buy” and a consensus price target of $88.27.

GE HealthCare Technologies Stock Performance

NASDAQ:GEHC opened at $72.75 on Thursday. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $94.80. The company has a quick ratio of 0.76, a current ratio of 0.98 and a debt-to-equity ratio of 0.73. The stock’s 50-day simple moving average is $70.11 and its 200 day simple moving average is $77.75. The firm has a market capitalization of $33.31 billion, a PE ratio of 15.32, a price-to-earnings-growth ratio of 2.43 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, April 30th. The company reported $1.01 earnings per share for the quarter, beating analysts’ consensus estimates of $0.91 by $0.10. The company had revenue of $4.78 billion for the quarter, compared to the consensus estimate of $4.66 billion. GE HealthCare Technologies had a net margin of 11.02% and a return on equity of 24.95%. The firm’s quarterly revenue was up 2.7% compared to the same quarter last year. During the same period last year, the company posted $0.90 EPS. On average, analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies declared that its Board of Directors has initiated a share buyback program on Wednesday, April 30th that authorizes the company to buyback $1.00 billion in shares. This buyback authorization authorizes the company to purchase up to 3.1% of its stock through open market purchases. Stock buyback programs are usually a sign that the company’s board of directors believes its shares are undervalued.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.